Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2527]

Bladder cancer research rife with new approaches

Bladder cancer research rife with new approaches

Intensity modulated pelvic radiation therapy reduces patient reported toxicities

Intensity modulated pelvic radiation therapy reduces patient reported toxicities

ASTRO 2016: Radiation therapy and radical prostatectomy explored further for initial diagnosis of advanced prostate cancer

ASTRO 2016: Radiation therapy and radical prostatectomy explored further for initial diagnosis of advanced...

$ASTRO 2016: Hypofractionated radiotherapy for prostate cancer can reduce treatment time by one-third with comparable QOL$

ASTRO 2016: Hypofractionated radiotherapy for prostate cancer can reduce treatment time by one-third with...

ASTRO 2016: Intermediate risk prostate cancer may be well controlled with brachytherapy alone

ASTRO 2016: Intermediate risk prostate cancer may be well controlled with brachytherapy alone

$ASTRO 2016: Promising toxicity results for intermediate risk prostate cancer patients undergoing extreme hypofractionation$

ASTRO 2016: Promising toxicity results for intermediate risk prostate cancer patients undergoing extreme...

ASTRO 2016: SBRT offers prostate cancer patients high cancer control and low toxicity in fewer treatments

ASTRO 2016: SBRT offers prostate cancer patients high cancer control and low toxicity in fewer treatments

ASTRO 2016: Three novel intrinsic subtypes of prostate cancer identified

ASTRO 2016: Three novel intrinsic subtypes of prostate cancer identified

Blood biomarkers identified in drug-resistant cancer cells

Blood biomarkers identified in drug-resistant cancer cells

UKAS accreditation of new 'hormone fingerprint' test for diagnosis of adrenal cancer

UKAS accreditation of new 'hormone fingerprint' test for diagnosis of adrenal cancer

More from ecancer